Open Access
CC BY-NC 4.0 · Arch Plast Surg 2015; 42(06): 686-694
DOI: 10.5999/aps.2015.42.6.686
Original Article

Wound Healing Effects of Rose Placenta in a Mouse Model of Full-Thickness Wounds

Authors

  • Yang Woo Kim

    Department of Plastic and Reconstructive Surgery, Gil Medical Center, Gachon University School of Medicine, Incheon, Korea
  • Seung Ryeol Baek

    Department of Plastic and Reconstructive Surgery, Gil Medical Center, Gachon University School of Medicine, Incheon, Korea
  • Eun Sook Lee

    Department of Plastic and Reconstructive Surgery, Gil Medical Center, Gachon University School of Medicine, Incheon, Korea
  • Sang Ho Lee

    Department of Pathology, Gil Medical Center, Gachon University School of Medicine, Incheon, Korea
  • Sang Hyun Moh

    Anti-Aging Research Institute, Bio-FD&C Co., LTD, Incheon, Korea
  • Soo Yun Kim

    Anti-Aging Research Institute, Bio-FD&C Co., LTD, Incheon, Korea
  • Ji Hong Moh

    Anti-Aging Research Institute, Bio-FD&C Co., LTD, Incheon, Korea
  • Chieko Kondo

    Ginza Tomato, Tokyo, Japan
  • Young Woo Cheon

    Department of Plastic and Reconstructive Surgery, Gil Medical Center, Gachon University School of Medicine, Incheon, Korea

Background Rosa damascena, a type of herb, has been used for wound healing in Eastern folk medicine. The goal of this study was to evaluate the effectiveness of rose placenta from R. damascena in a full-thickness wound model in mice.

Methods Sixty six-week-old C57BL/6N mice were used. Full-thickness wounds were made with an 8-mm diameter punch. Two wounds were made on each side of the back, and wounds were assigned randomly to the control and experimental groups. Rose placenta (250 µg) was injected in the experimental group, and normal saline was injected in the control group. Wound sizes were measured with digital photography, and specimens were harvested. Immunohistochemical staining was performed to assess the expression of epidermal growth factor (EGF), vascular endothelial growth factor (VEGF), transforming growth factor-β1 (TGF-β1), and CD31. Vessel density was measured. Quantitative analysis using an enzyme-linked immunosorbent assay (ELISA) for EGF was performed. All evaluations were performed on postoperative days 0, 2, 4, 7, and 10. Statistical analyses were performed using the paired t-test.

Results On days 4, 7, and 10, the wounds treated with rose placenta were significantly smaller. On day 2, VEGF and EGF expression increased in the experimental group. On days 7 and 10, TGF-β1 expression decreased in the experimental group. On day 10, vessel density increased in the experimental group. The increase in EGF on day 2 was confirmed with ELISA.

Conclusions Rose placenta was found to be associated with improved wound healing in a mouse full-thickness wound model via increased EGF release. Rose placenta may potentially be a novel drug candidate for enhancing wound healing.

This research was supported by the Basic Science Research Program through the National Research Foundation of Korean (NRF), funded by the Ministry of Science, ICT & Future Planning (NRF-2014R1A1A 1037258) and a research-focused grant from Gil Hospital (FRD 2013-41). This research was also supported by research foundation of Gachon university (GCU-2013-M055).




Publication History

Received: 07 July 2015

Accepted: 21 September 2015

Article published online:
05 May 2022

© 2015. The Korean Society of Plastic and Reconstructive Surgeons. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonCommercial License, permitting unrestricted noncommercial use, distribution, and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes. (https://creativecommons.org/licenses/by-nc/4.0/)

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA